Page last updated: 2024-10-16

beta-alanine and Allergic Encephalomyelitis

beta-alanine has been researched along with Allergic Encephalomyelitis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Future treatments of multiple sclerosis (MS), a chronic autoimmune neurodegenerative disease of the central nervous system (CNS), aim for simultaneous early targeting of peripheral immune function and neuroinflammation."1.56Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. ( Balletta, S; Bruno, A; Bullitta, S; Buttari, F; Caioli, S; Centonze, D; De Vito, F; Dolcetti, E; Fresegna, D; Gentile, A; Guadalupi, L; Mandolesi, G; Musella, A; Nencini, M; Rizzo, FR; Sanna, K; Stampanoni Bassi, M; Vanni, V; Vitiello, L, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Musella, A1
Gentile, A1
Guadalupi, L1
Rizzo, FR1
De Vito, F1
Fresegna, D1
Bruno, A1
Dolcetti, E1
Vanni, V1
Vitiello, L1
Bullitta, S1
Sanna, K1
Caioli, S1
Balletta, S1
Nencini, M1
Buttari, F1
Stampanoni Bassi, M1
Centonze, D1
Mandolesi, G1
Galicia-Rosas, G1
Pikor, N1
Schwartz, JA1
Rojas, O1
Jian, A1
Summers-Deluca, L1
Ostrowski, M1
Nuesslein-Hildesheim, B1
Gommerman, JL1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study[NCT05245344]154 participants (Anticipated)Observational2022-04-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for beta-alanine and Allergic Encephalomyelitis

ArticleYear
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Cells, 2020, 05-22, Volume: 9, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; beta-Alanine; Cell Line; Central Nervous System; Disease Models,

2020
A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Oct-01, Volume: 189, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; beta-Alanine; Cell Aggregation; Den

2012